TY - JOUR
T1 - Advancing Sexual Harassment Prevention and Elimination in the Sciences
T2 - "Every. Health Organization Must Do Something Similar"
AU - Jennings, Jacky M.
AU - Grieb, Suzanne M.
AU - Rietmeijer, Cornelis
AU - Gaydos, Charlotte A.
AU - Hawkins, Rima
AU - Thurston, Rebecca C.
AU - Blanchard, James
AU - Cameron, Caroline E.
AU - Lewis, David A.
N1 - Publisher Copyright:
© Lippincott Williams & Wilkins.
PY - 2022/10/1
Y1 - 2022/10/1
N2 - Background Sexual harassment is pervasive in science. A 2018 report found that the prevalence of sexual harassment in academia in the United States is 58%. An activity held at an international scientific congress was designed to advance sexual harassment prevention and elimination and empower binary and nonbinary persons at risk for harassment, discrimination, and violence. The objective is to describe the activity and outcomes to provide a promising model for other scientific communities. Methods A description of the plenary and key components as well as the data collection and analysis of selected outcomes are provided. Results Among 1338 congress participants from 61 countries, 526 (39%) attended the #MeToo plenary, and the majority engaged in some way during the plenary session. Engagement included standing for the pledge (85%), participating in the question and answer session (n = 5), seeking counseling (n = 3), and/or providing written post-it comments (n = 96). Respondents to a postcongress survey (n = 388 [24% of all attendees]) ranked the plenary as number 1 among 14 congressional plenaries. In postanalysis, the written post-it comments were sorted into 14 themes within 6 domains, including: (1) emotional responses, (2) barriers to speaking out, (3) public health priorities, (4) reframing narratives about the issue, (5) allyship, and (6) moving the issue forward. Conclusions Scientific organizations, agencies, and institutions have an important role to play in setting norms and changing enabling policies toward a zero-tolerance culture of sexual harassment. The activity presented offers a promising model for scientific communities with similar goals. The outcomes suggest that the plenary successfully engaged participants and had a measurable impact on the participants.
AB - Background Sexual harassment is pervasive in science. A 2018 report found that the prevalence of sexual harassment in academia in the United States is 58%. An activity held at an international scientific congress was designed to advance sexual harassment prevention and elimination and empower binary and nonbinary persons at risk for harassment, discrimination, and violence. The objective is to describe the activity and outcomes to provide a promising model for other scientific communities. Methods A description of the plenary and key components as well as the data collection and analysis of selected outcomes are provided. Results Among 1338 congress participants from 61 countries, 526 (39%) attended the #MeToo plenary, and the majority engaged in some way during the plenary session. Engagement included standing for the pledge (85%), participating in the question and answer session (n = 5), seeking counseling (n = 3), and/or providing written post-it comments (n = 96). Respondents to a postcongress survey (n = 388 [24% of all attendees]) ranked the plenary as number 1 among 14 congressional plenaries. In postanalysis, the written post-it comments were sorted into 14 themes within 6 domains, including: (1) emotional responses, (2) barriers to speaking out, (3) public health priorities, (4) reframing narratives about the issue, (5) allyship, and (6) moving the issue forward. Conclusions Scientific organizations, agencies, and institutions have an important role to play in setting norms and changing enabling policies toward a zero-tolerance culture of sexual harassment. The activity presented offers a promising model for scientific communities with similar goals. The outcomes suggest that the plenary successfully engaged participants and had a measurable impact on the participants.
UR - http://www.scopus.com/inward/record.url?scp=85138453799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138453799&partnerID=8YFLogxK
U2 - 10.1097/OLQ.0000000000001683
DO - 10.1097/OLQ.0000000000001683
M3 - Article
C2 - 35921636
AN - SCOPUS:85138453799
SN - 0148-5717
VL - 49
SP - 663
EP - 668
JO - Sexually Transmitted Diseases
JF - Sexually Transmitted Diseases
IS - 10
ER -